Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot inpatient trial of liraglutide plus basal insulin versus basal-bolus insulin for glucocorticoid-induced or glucocorticoid-exacerbated diabetes
ACTRN12615000333516Phase 4Terminated
- Sponsor
- The Alfred Hospital
- Start
- May 2014
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of liraglutide and human insulin in steroid-induced diabetes and diabetes mellitus (DM) (2 arms), sponsored by The Alfred Hospital. Primary endpoint: Time spent with normoglycaemia. Started May 2014; status: terminated.
02
Drugs
liraglutidehuman insulin
03
Conditions
steroid-induced diabetesdiabetes mellitus (DM)
Beyond the preview
Go deeper on ACTRN12615000333516.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12615000333516.